Depending on adoption rates, the total GLP-1 market could reach as much as $240 billion, in the most optimistic scenario, or $170 billion, in a more conservative case
These conditions typically include type 2 diabetes, high blood pressure, high cholesterol, or sleep apnea
Gulf Cooperation Council states added semaglutide to formularies in 2024-2025, although high list prices restrict access to insured populations
Retatrutide and other triple agonist peptides sold by Canadian research peptide suppliers are for laboratory use only and are not approved by Health Canada for human or veterinary therapeutic use
Common Mistakes When Buying Glutathione in India Mistake 1: Choosing Based on Price Alone The cheapest glutathione supplement is almost never the best value
Meeting the challenge of virtual diabetes care: a consensus viewpoint on the positioning and value of oral semaglutide in routine clinical practice